Mauer Alexandre da Ascensão Gonçalves, Rafael Antônio Vicente Lacerda, Humberto Morais, Fidel Manuel Caceres-Loriga, Howard Lopes Ribeiro Junior.
Cardiovascular innovation without equity risks widening global gaps.
MedScience DOI:10.1007/s11684-026-1262-7
Ahadzi D, Gaye B, Commodore-Mensah Y. Advancing the cardiovascular workforce in Africa to tackle the epidemic of cardiovascular disease: the time is now. Glob Heart2023; 18(1): 20
[2]
World Health Organization. Cardiovascular diseases (CVDs). Fact sheet. Geneva: World Health Organization; 31 Jul 2025. Available at the website of who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
[3]
Khan Z, Nadar SK. Spotlight on hypertension in the African Continent. J Hum Hypertens2025; 39(2): 80–82
[4]
Aikawa M, Sonawane AR, Chelvanambi S, Asano T, Halu A, Matamalas JT, Singh SA, Uchida S, Aikawa E, Arenas A, Balligand JL, Giannarelli C, MacRae CA, Morgan NV, Oury C, Stahel HT, Loscalzo J. Precision cardiovascular medicine: shifting the innovation paradigm. Front Sci2025; 3: 1474469
[5]
Mapesi H, Rohacek M, Vanobberghen F, Gupta R, Wilson HI, Lukau B, Amstutz A, Lyimo A, Muhairwe J, Senkoro E, Byakuzana T, Nkouabi J, Mbunda G, Siru J, Tarr A, Ramapepe E, Mphunyane M, Oehri J, Nemtsova V, Yan X, Bresser M, Glass TR, Paris DH, Fink G, Gingo W, Labhardt ND, Burkard T, Weisser M. Treatment strategies to control blood pressure in people with hypertension in Tanzania and Lesotho: a randomized clinical trial. JAMA Cardiol2025; 10(4): 321–333
[6]
Shogade TT, Effiong BA, Udosen AU, Markson FE, Nkanga KE, Tanimowo MO, Ekrikpo UE, Ekpe EE, Ojji DB.. Trend in the prevalence, awareness, treatment and control of hypertension among adult over in Nigeria over a 4-year period.. Eur Heart J2024; 45(Suppl 1): ehae666.2563
[7]
Criveanu C, Doran NM, Gheorghiță V, Stăiculescu O. Innovating for health: measuring the path of global innovation in healthcare systems. Healthcare (Basel)2025; 13(23): 3167
[8]
Seedat Y, Ali A, Ferdinand KC. Hypertension and cardiovascular disease in the sub-Saharan African context. Ann Transl Med2018; 6(15): 297
[9]
Yenet A, Nibret G, Tegegne BA. Challenges to the availability and affordability of essential medicines in African countries: a scoping review. Clinicoecon Outcomes Res2023; 15: 443–458
[10]
Sethi Y, Patel N, Kaka N, Kaiwan O, Kar J, Moinuddin A, Goel A, Chopra H, Cavalu S. Precision medicine and the future of cardiovascular diseases: a clinically oriented comprehensive review. J Clin Med2023; 12(5): 1799
[11]
Sivasubramaniam S, Muniasamy K, L E, Pradeep S, D R, S Y, Baskaran SNK, Srikanth KA. Research landscape of precision medicine in cardiology. Bioinformation2025; 21(7): 1886–1890
[12]
Hudson JA, Sanga L, Jobe M, Etyang AO, McAllister D, Perel P, Shah AS, Ogola EN. Sub-Saharan Africa’s contribution to clinical trials in international acute coronary syndromes and heart failure guidelines. JACC Adv2024; 3(12): 101383
[13]
Shah K, Sharma K, Saxena D. Editorial: health technology assessment in cardiovascular diseases. Front Cardiovasc Med2023; 10: 1108503
[14]
World Health Organization. HEARTS technical package for cardiovascular disease management in primary health care: risk-based CVD management. Geneva: World Health Organization; 2020. Published July 13, 2020. Available at the website of who. int/publications/i/item/9789240001367
[15]
Jeemon P, Séverin T, Amodeo C, Balabanova D, Campbell NRC, Gaita D, Kario K, Khan T, Melifonwu R, Moran A, Ogola E, Ordunez P, Perel P, Piñeiro D, Pinto FJ, Schutte AE, Wyss FS, Yan LL, Poulter NR, Prabhakaran D. World Heart Federation roadmap for hypertension—a 2021 update. Glob Heart2021; 16(1): 63
[16]
Warren J. The history of appropriate use criteria in cardiovascular diagnostic imaging: bridging the past, present, and future. J Nucl Med Technol2025; 53(4): 275–280
[17]
Yuyun MF, Sliwa K, Kengne AP, Mocumbi AO, Bukhman G. Cardiovascular diseases in sub-Saharan Africa compared to high-income countries: an epidemiological perspective. Glob Heart2020; 15(1): 15
PDF
(250KB)
